openPR Logo
Press release

Uterine Fibroids Treatment Market Size, Insights, Outlook, Overview And Report To 2024-2033

Uterine Fibroids Treatment Market

Uterine Fibroids Treatment Market

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Uterine Fibroids Treatment Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The uterine fibroids treatment market size has grown rapidly in recent years. It will grow from $3.67 billion in 2023 to $4.04 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increased incidence of uterine fibroids, advancements in diagnostic techniques, rising awareness and education, impact on quality of life, evolution of minimally invasive procedures..

The uterine fibroids treatment market size is expected to see strong growth in the next few years. It will grow to $5.77 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to advancements in non-invasive treatment, increasing emphasis on fertility preservation, rise in minimally invasive techniques, personalized medicine approaches, collaborative research and development.. Major trends in the forecast period include rising focus on fertility-preserving treatments, integration of imaging technologies in treatment planning, increasing awareness and education initiatives, customized treatment plans based on patient profiles, exploration of novel therapeutic targets..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=10766&type=smp

Market Segmentation:
The uterine fibroids treatment market covered in this report is segmented -

1) By Type: Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids, Pedunculated Fibroids
2) By Treatment Type: Hormone Therapy, Androgens, Gonadotropin-Releasing Hormone Antagonists, Uterine Artery Embolization, Myomectomy, Hysterectomy
3) By End-Users: Hospitals, Ambulatory Surgical Centers, Other End users

Major Driver - Rising Prevalence Of Uterine Fibroids Propels Growth In Treatment Market
The high prevalence of uterine fibroids among women is expected to propel the growth of the uterine fibroids treatment market going forward. Uterine fibroids refer to non-cancerous growths that develop in the uterus and can cause symptoms such as heavy menstrual bleeding, pelvic pain, and pressure on the bladder or bowel. Uterine fibroids treatment treats fibroids by blocking the production of estrogen and progesterone and stopping and improving anemia. For instance, in November 2022, according to a report published by the National Centre for Biotechnology Information, a US-based organization, and branch of the National Institutes of Health, the approximate incidence of uterine fibroids occurs between 40 and 60% among women under the age of 35 and between 70- 80% among women over the age of 50. Therefore, the high prevalence of uterine fibroids among women worldwide is driving the growth of the uterine fibroids treatment market.

Competitive Landscape:
Major companies operating in the uterine fibroids treatment market report are Gynesonics Inc., Medtronic plc, Boston Scientific Corporation, Karl Storz GmbH, Pfizer Inc., Abbvie Inc., Richard Wolf GmbH, CooperSurgical Inc., Olympus Corporation, Myovant Sciences GmbH, Insightec Ltd., Hologic Inc., Obseva SA, Eli Lilly and Company, GlaxoSmithKline plc, Stryker Corporation, Smith & Nephew plc, Minerva Surgical Inc., Ethicon Inc., Cook Medical LLC, C.R. Bard Inc., Biomerics LLC, Visionsense Corp., Halt Medical Inc., Acessa Health Inc., Blue Endo, LiNA Medical ApS, Merit Medical Systems Inc., Allergan plc, Astellas Pharma Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/uterine-fibroids-treatment-global-market-report

Top Trend - Innovative Products Drive Momentum In Uterine Fibroid Treatment Market
Product innovations are a key trend gaining popularity in the uterine fibroid treatment market. Companies operating in the uterine fibroid treatment market are adopting innovative products to sustain their position in the market. For instance, in May 2021, Myovant Sciences, a Switzerland-based healthcare company, and Pfizer, a US-based multinational pharmaceutical and biotechnology corporation, received FDA approval for MYFEMBREE (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg). This is the first once-daily treatment with a maximum 24-month treatment duration for the control of severe monthly bleeding brought on by uterine fibroids in premenopausal women.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Uterine Fibroids Treatment Market Characteristics
3. Uterine Fibroids Treatment Market Trends And Strategies
4. Uterine Fibroids Treatment Market - Macro Economic Scenario
5. Uterine Fibroids Treatment Market Size And Growth
…..
27. Uterine Fibroids Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uterine Fibroids Treatment Market Size, Insights, Outlook, Overview And Report To 2024-2033 here

News-ID: 3394788 • Views:

More Releases from The Business research company

Masks (N95 Respirators And Other Surgical Masks) Global Market Analysis, Trends, Growth, Research And Forecast 2033
Masks (N95 Respirators And Other Surgical Masks) Global Market Analysis, Trends, …
The masks (n95 respirators and other surgical masks) market size has grown strongly in recent years. It will grow from $14.49 billion in 2023 to $15.6 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to impact of covid-19 pandemic, rising air pollution levels, escalating number of smokers, increased number of surgical procedures, a rise in
Insurance Brokers Market Share, Trends, Growth Rate, Industry Report And Forecast To 2033
Insurance Brokers Market Share, Trends, Growth Rate, Industry Report And Forecas …
The insurance brokers market size has grown strongly in recent years. It will grow from $100.7 billion in 2023 to $105.81 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to strong economic growth in emerging markets, government led insurance reforms, increasing healthcare costs, and impact of covid-19. The insurance brokers market size is expected to see
Seasoning And Dressing Global Market Navigating Trends, Share Report, Growth Drivers, Market Size And Future Outlook 2024-2033 | Unilever, Kerry Group, Nestle S.A, MDH Spices, DS Group
Seasoning And Dressing Global Market Navigating Trends, Share Report, Growth Dri …
The seasoning and dressing market size has grown strongly in recent years. It will grow from $152.56 billion in 2023 to $163.4 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to strong economic growth in emerging markets, rise in disposable income, impact of covid 19 lockdown and rising preference for convenience and processed food products. The
Lead Acid Batteries Global Market Analysis, Trends, Growth, Research And Forecast 2033
Lead Acid Batteries Global Market Analysis, Trends, Growth, Research And Forecas …
The lead acid batteries market size has grown rapidly in recent years. It will grow from $28.86 billion in 2023 to $32.02 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to strong economic growth in emerging markets, rapid growth in the automotive industry and rising demand for renewable energy. The lead acid batteries market size is

All 5 Releases


More Releases for Fibroid

Uterine Fibroid Treatment Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Uterine Fibroid Treatment market analysis, which studies the Uterine Fibroid Treatment's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Uterine Fibroid Treatment Market 2020-2025” Research Report categorizes the global Uterine Fibroid Treatment market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players
Uterine fibroid treatment Market: Regional markets, technology, types, and appli …
Uterine fibroids (myoma) are benign (non-cancerous) lumps that grow in the muscular wall of the uterus. They vary in sizes, from minute (a quarter of an inch) to the size of more than16 centimeters. The incidence of uterine fibroid is about 20%–40% in women during their reproductive ages. Occasionally, these fibroids swell up and make the uterus to grow like full visible pregnancy. Mostly, there are more than one fibroid
Uterine fibroid treatment Market | Key Trends and Forecast Research Report 2023
Uterine fibroids (myoma) are benign (non-cancerous) lumps that grow in the muscular wall of the uterus. They vary in sizes, from minute (a quarter of an inch) to the size of more than16 centimeters. The incidence of uterine fibroid is about 20%–40% in women during their reproductive ages. Occasionally, these fibroids swell up and make the uterus to grow like full visible pregnancy. Mostly, there are more than one fibroid
United States Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023
ReportsWorldwide has announced the addition of a new report title United States Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023 to its growing collection of premium market research reports. GlobalData’s new report, "United States Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023", provides key procedures data on the United States Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve
Spain Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023
ReportsWorldwide has announced the addition of a new report title Spain Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023 to its growing collection of premium market research reports. GlobalData’s new report, "Spain Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023", provides key procedures data on the Spain Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures and
Germany Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023
ReportsWorldwide has announced the addition of a new report title Germany Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023 to its growing collection of premium market research reports. GlobalData’s new report, "Germany Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023", provides key procedures data on the Germany Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures and